TRACON PHARMACEUTICALS INC COM USD0.001

I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in the U.S. Phase 1 Clinical Trial of the CD73 Antibody TJD5 in Patients with Advanced Solid Tumors

01 Aug 2019 13:05:07 By Nasdaq GlobeNewswire

TRACON to Report Second Quarter 2019 Company Highlights and Financial Results on August 7, 2019

31 Jul 2019 21:06:51 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: TRACON PHARMACEUTICALS INC COM USD0.001

30 Jul 2019 21:11:55 By NetDania Notify

NetDania - New 12 months Low: TRACON PHARMACEUTICALS INC COM USD0.001

29 Jul 2019 18:48:02 By NetDania Notify

TRACON Pharmaceuticals to Participate in Wells Fargo Securities 2019 Biotech Corporate Access Day

29 Jul 2019 13:05:01 By Nasdaq GlobeNewswire

TRACON Pharmaceuticals Provides Update on Phase 1/2 Trial of TRC253 in Patients with Metastatic Castrate Resistant Prostate Cancer

02 Jul 2019 13:05:08 By Nasdaq GlobeNewswire

TRACON Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference

30 May 2019 13:05:17 By Nasdaq GlobeNewswire

TRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update

14 May 2019 21:04:14 By Nasdaq GlobeNewswire

TRACON to Report First Quarter 2019 Company Highlights and Financial Results on May 14, 2019

07 May 2019 21:06:06 By Nasdaq GlobeNewswire

TRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee

12 Apr 2019 11:55:00 By Nasdaq GlobeNewswire

TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

28 Feb 2019 21:02:31 By Nasdaq GlobeNewswire

TRACON to Report Fourth Quarter and Full Year 2018 Company Highlights and Financial Results on February 28, 2019

21 Feb 2019 21:03:23 By Nasdaq GlobeNewswire

TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma

22 Jan 2019 13:32:05 By Nasdaq GlobeNewswire

TRACON Pharmaceuticals Presents Positive Top-line Clinical Data from Dose Escalation Portion of Phase 1 Trial of TRC105 and Opdivo® for Treatment of Non-Small Cell Lung Cancer

26 Dec 2018 21:05:23 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: TRACON PHARMACEUTICALS INC COM USD0.001

26 Dec 2018 16:24:56 By NetDania Notify

TRACON Pharmaceuticals Announces Submission of IND Application for TJ4309 (CD73 Antibody TJD5) for Treatment of Advanced Solid Tumors

26 Dec 2018 13:35:11 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: TRACON PHARMACEUTICALS INC COM USD0.001

21 Dec 2018 15:23:30 By NetDania Notify

TRACON Pharmaceuticals Announces Top-line Data from Phase 2 TRAXAR Clinical Trial in Renal Cell Carcinoma

21 Dec 2018 13:10:19 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: TRACON PHARMACEUTICALS INC COM USD0.001

18 Dec 2018 14:45:01 By NetDania Notify

NetDania - New 12 months Low: TRACON PHARMACEUTICALS INC COM USD0.001

17 Dec 2018 15:08:01 By NetDania Notify